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The Ending Eclampsia project seeks to expand access                
to proven, underutilized interventions and commodities             
for the prevention, early detection, and treatment of pre-
eclampsia and eclampsia and strengthen global partnerships.
Despite global efforts to reduce 
preventable maternal and neonatal 
mortality, Nigeria’s maternal mortality ratio 
is estimated at 576 deaths per 100,000 
live births and neonatal death is estimated 
at 37 per 1,000 live births 1.
Maternal and newborn deaths due to pre-eclampsia and 
eclampsia (PE/E) are preventable, yet in Nigeria this is the most 
significant direct cause of maternal deaths. 
To appreciate the enormity of this problem at country and state 
levels, a landscape analysis was conducted by the Population 
Council in 2015 on PE/E in seven states in Nigeria. The main 
objectives of the landscape analysis were: 
• To understand the level of programmatic and policy 
support for PE/E prevention and treatment;
• To analyze the gaps in providers’ knowledge and 
competence in preventing, detecting, and managing PE/E;
• To determine primary health care (PHC) facilities’ 
capacities to manage PE/E;
• To assess community awareness, beliefs, and experiences 
around PE/E;
• To understand the volume of research on PE/E in the last 
15 years; and
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PE/E IN BRIEF
• Pre-eclampsia is a condition               
in pregnant women marked by an 
increase in blood pressure and 
protein in urine after 20 weeks 
gestation.
• Providing high quality antenatal care 
improves the prevention and early 
detection of pre-eclampsia and can 
prevent its progression to eclampsia.
• Eclampsia is a life-threatening 
condition characterized by 
convulsions in women with PE.
• Women in developing countries are 
300 times more likely to die from 
eclampsia than women in developed 
countries.
• Prescribing low-dose aspirin and 
calcium to at-risk women can prevent 
pre-eclampsia and eclampsia.
• Pre-eclampsia and eclampsia can 
be managed by administering anti-
hypertensive drugs and magnesium 
sulphate (MgSO4).
• MgSO4 is the safest and most 
effective treatment for severe PE/E, 
and is one of 13 UN Life-Saving 
Commodities for Women and 
Children. 
• PE/E and other hypertensive 
disorders in pregnancy increase the 
risk of pre-term births, which can 
lead to low birth weight, anemia, and 
stunting.
• Improved prevention, increased 
detection, and effective treatment 
of PE/E can prevent unnecessary 
maternal and newborn deaths.
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FIGURE 1    Proportion of facilities with the key 
equipment to detect PE and manage severe PE/E
FACILITY CAPACITY AND 
PREPAREDNESS
To assess institutional preparedness, researchers 
visited 20 facilities in Ebonyi State and recorded that 
two (10%) of the facilities had guidelines available for 
management of pre-eclampsia, five (25%) had all ANC 
equipment for the detection of PE/E and five (25%) use 
MgSO4 for the treatment of eclampsia. 
“It depends on the capacity of 
the staff in primary care center 
because MgSO4 is not something 
anybody can administer… we only 
allow MgSO4 to be administered by 
midwives and registered nurses.” 
—POLICYMAKER, EBONYI
During facility assessments, researchers determined if 
the facilities had the key ANC equipment required to 
detect pre-eclampsia, to manage severe PE/E, and to 
monitor for MgSO4 toxicity (figure 1).
Three (15%) of facility managers reported always using 
MgSO4 to treat PE/E, three (15%) said it is sometimes 
used, and 14 (70%) reported that it is never used. 
When asked how they obtain MgSO4 supplies at the 
facility, the Council found that 33% receive it routinely 
from central supply, 50% purchase it locally, and 17% 
said they procure it elsewhere (such as NGOs).
Although most of the hospitals assessed have capacity 
to provide basic signal functions for emergency 
obstetric and newborn care (EmONC), Table 1 shows 
that few have the capacity to provide parenteral 
anticonvulsants (MgSO4) and only one hospital actually 
used MgSO4 in the past three months preceding the 
survey. 
FIGURE 2    Provider knowledge on drugs for 
prevention and management of PE/E (n=46)
PROVIDER KNOWLEDGE AND 
SKILLS
Two-thirds and more than three quarters of providers 
knew the signs and symptoms of PE and eclampsia 
respectively. Only 52%, however, could correctly 
identify chronic hypertension and 9% could recall 
signs and symptoms of severe pre-eclampsia.
Researchers also assessed health care providers’ 
knowledge of drugs used for preventing and managing 
PE/E as well as calcium gluconate to treat MgSO4 
toxicity (figure 2).
Figure 2 shows limited provider knowledge on 
prophylactic use of calcium and aspirin for women 
TABLE 1    Signal functions for Emergency 
Obstetric and Newborn Care (EmONC)
Of concern is the limited capacity to provide cesarean 
section, neonatal resuscitation and blood transfusion. 
PHCs in Ebonyi also have a mixed picture in their 
capacity to provide EmONC with very few providing 
MgSO4.
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FIGURE 3    Percent of clients who received all 
eight components of ANC
COMMUNITY KNOWLEDGE 
AND PERCEPTIONS
The study also conducted in-depth interviews (IDIs) 
and focus group discussions (FGDs) for qualitative 
information from PE/E survivors, community 
stakeholders and families affected by PE/E. 
During FGDs with married men, participants reported 
poverty, lack of funds to take care of life during 
pregnancy, husbands’ waywardness, listening to 
stories of pregnancy worries, baby not in good position, 
self-medication, staying long before conception, and 
drinking alcohol as causes of high blood pressure, 
swelling, and bleeding in pregnancy. Men’s solutions 
to prevent these complications included: encouraging 
pregnant women to go for ANC early, identifying the 
problem and notifying health workers, government 
assistance, avoiding self-medication, and always eating 
a balanced diet.
Women also stated that high BP during pregnancy is 
caused by ‘over thinking’, age, early marriage, hardship, 
maltreatment from husbands, poverty, as well as the 
baby is not breathing well, engaging in stress-inducing 
activities, caring for husband, business and children, or 
seeking a male child. Women also discussed seeking 
help for high blood pressure from the hospital or the 
herbal homes.
“High blood pressure will make 
your legs rise and you will think 
whether you will die.” 
—FEMALE FGD PARTICIPANT, EBONYI
“They will put charcoal into the pot 
with other medicine and a child will 
be placed in between, believing this 
will cool the sickness.” 
—FEMALE FGD PARTICIPANT, EBONYI
Overall, the qualitative findings showed that the 
signs and symptoms associated with PE/E are often 
attributed to other causes and that community 
members often seek care from either hospitals or 
herbal homes. Misconceptions, myths, and mistrust 
between communities and health providers negatively 
influence care-seeking behaviors.
at risk of PE and which anti-hypertensives (aldomet 
or nifedipine) to use for managing high BP during 
pregnancy. The Pritchard regimen for MgSO4 
administration is considered the ‘gold standard’ for 
preventing and treating convulsions in severe PE/E, 
but few providers (11%) could accurately describe 
the appropriate loading dose of MgSO4 or name the 
antidote for MgSO4 toxicity, calcium gluconate (7%).
QUALITY OF CARE
Quality of antenatal care was assessed through 
observations of 10 client-provider interactions and 10 
client exit interviews. 
Clients should receive eight components of quality 
antenatal care at each visit, and researchers asked 
the 10 clients whether their health provider completed 
each component during the consultation (figure 3).
In addition to the eight essential components of ANC, 
questions and tests should be conducted to assess a 
woman’s risk of developing PE/E, to detect PE/E, and 
inform clients of the signs of impending eclampsia. 
During 30% of the observed ANC consultations, 
providers performed the necessary checks to detect 
women at risk of developing PE. These included history 
of high blood pressure (BP) and diabetes, date of last 
delivery, client’s parity, age and weight, edema of face, 
hands, legs, and ankles. In addition, 50% of providers 
observed in Ebonyi measured women’s BP and checked 
urine for protein and 30% of the providers advised 
the clients on the symptoms of impending eclampsia 
(severe headache, blurred vision, and pre-eclampsia 
with generalized body swelling).
SURVIVORS EXPERIENCES
Interviews with survivors documented their care-
seeking pathways, including their PE/E experience, the 
availability and accessibility of essential services and 
commodities, and the outcomes of the pregnancy for 
mother and child. The quotation below describes one 
young woman’s experience with PE/E:
“I am 23 years old. I saw my doctor, 
he attended to me and prescribed 
my routine drugs and there was no 
problem. My BP was measured as 
well as my urine. During that time, I 
suffered from severe headache, no 
blurred vision. I had swelling feet but 
no convulsion. My husband assisted 
me in the household activities so that 
I could rest; my mother-in-law was not 
around. They helped [me] through 
prayer and said it is good to go to 
hospital... They [Health providers] 
attended to me well. I paid for the 
drugs and treatment, and it wasn’t 
high, [but] I lost that baby. ” 
—PE/E SURVIVOR, EBONYI
DISCUSSION & CONCLUSION
This landscape analysis in Ebonyi identified the gaps 
in facilities’ and providers’ capacities for preventing, 
detecting, and managing PE/E; assessing community 
awareness, beliefs, and experiences of PE/E; and 
determined priority areas for research and programs to 
improve access to prevention and treatment.
State-level policymakers are aware of some polices but 
there are differing opinions on task-shifting to lower 
cadres, especially concerning administering MgSO4 
loading dose at PHC level.
There is a mixed picture regarding the signal functions 
for EmONC. Facilities have shortages of equipment, 
drugs, and supplies to detect PE/E and few have MgSO4 
and calcium gluconate in stock. Very few hospitals 
appear to have the capacity to conduct cesarean 
sections or resuscitate newborns. 
Provider knowledge is weak on the signs and symptoms 
as well as which drugs to use for prevention and 
treatment of PE/E. 
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Regarding quality of ANC, while all women interviewed 
said that the provider checked her blood pressure only 
40% check for proteinuria. Providers do not check 
for women at high risk of developing PE/E nor give 
information for danger signs. 
There is some knowledge on PE/E and other problems 
in pregnancy. Men seem willing to support their wives 
and encourage them to go for ANC and seek emergency 
care from hospitals. Women describe stress (by over 
thinking and hard physical work) as a major contributor 
to PE, but seem to seek care at herbal clinics for high 
blood pressure.
A multi-pronged approach is required to address the 
health system issues and community perceptions 
that create barriers to women accessing quality care 
during pregnancy and for complications of pregnancy. 
Early detection and management of PE/E is critical to 
improve maternal and newborn survival in Nigeria. 
RECOMMENDATIONS
• Advocacy for streamlining state procurement and 
linking with existing distribution systems in Nigeria;
• Connect to work on the 13 UN Life-Saving 
Commodities for Women and Children: maternal 
drugs include MgSO4;
• Review policy documents, guidelines, treatment 
protocols and algorithms to ensure alignment with 
global and national policies. 
• Introduce task-shifting policy on MNH policy 
implementation plan for management of PE/E.
• Train all levels of providers on quality ANC: what, 
why, who, how, when and where; early detection 
of PE and management of severe PE/E (including 
anti-hypertensives and MgSO4 loading dose at PHC 
level).
• Community awareness campaigns to encourage 
early ANC and health-seeking behavior for 
complications. 
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